The FY2016 EPS Estimates for Thermo Fisher Scientific Inc. (TMO) Increased by Jefferies Group

The FY2016 EPS Estimates for Thermo Fisher Scientific Inc. (TMO) Increased by Jefferies Group

Thermo Fisher Scientific Inc. (NYSE:TMO) – Analysts at Jefferies Group lifted their FY2016 earnings per share (EPS) estimates for Thermo Fisher Scientific in a research report issued on Tuesday. Jefferies Group analyst B. Couillard now anticipates that the brokerage will post earnings of $8.25 per share for the year, up from their previous estimate of $8.15. Jefferies Group currently has a “Hold” rating on the stock. Jefferies Group also issued estimates for Thermo Fisher Scientific’s Q4 2016 earnings at $2.43 EPS, Q1 2017 earnings at $2.02 EPS, Q2 2017 earnings at $2.29 EPS, Q4 2017 earnings at $2.66 EPS and FY2018 earnings at $10.15 EPS.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, July 28th. The company reported $2.03 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.01 by $0.02. Thermo Fisher Scientific had a net margin of 11.35% and a return on equity of 14.70%. The company earned $4.54 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter last year, the business earned $1.84 EPS. The business’s revenue was up 6.2% on a year-over-year basis.

A number of other research analysts have also recently commented on the stock. Bank of America Corp. set a $180.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Friday, October 7th. JPMorgan Chase & Co. initiated coverage on shares of Thermo Fisher Scientific in a research note on Thursday, September 22nd. They issued an “overweight” rating and a $180.00 price target for the company. Cleveland Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Friday, September 9th. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Finally, Citigroup Inc. lifted their price target on shares of Thermo Fisher Scientific from $160.00 to $182.00 and gave the stock a “buy” rating in a research note on Friday, July 29th. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $162.72.

Thermo Fisher Scientific (NYSE:TMO) traded down 0.52% during mid-day trading on Wednesday, hitting $154.09. 456,342 shares of the stock traded hands. Thermo Fisher Scientific has a 1-year low of $119.75 and a 1-year high of $160.68. The firm has a market cap of $60.75 billion, a price-to-earnings ratio of 30.82 and a beta of 0.97. The stock has a 50-day moving average of $153.50 and a 200 day moving average of $150.90.

In related news, CEO Marc N. Casper sold 28,797 shares of the company’s stock in a transaction dated Friday, September 2nd. The shares were sold at an average price of $151.01, for a total value of $4,348,634.97. Following the completion of the sale, the chief executive officer now owns 307,444 shares of the company’s stock, valued at $46,427,118.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Marc N. Casper sold 30,000 shares of the company’s stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $151.17, for a total transaction of $4,535,100.00. Following the completion of the sale, the chief executive officer now directly owns 308,647 shares of the company’s stock, valued at approximately $46,658,166.99. The disclosure for this sale can be found here. 0.52% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the company. Moors & Cabot Inc. increased its stake in Thermo Fisher Scientific by 0.4% in the second quarter. Moors & Cabot Inc. now owns 1,994 shares of the company’s stock valued at $294,000 after buying an additional 7 shares during the last quarter. Brown Advisory Securities LLC increased its stake in Thermo Fisher Scientific by 0.4% in the second quarter. Brown Advisory Securities LLC now owns 2,388 shares of the company’s stock valued at $353,000 after buying an additional 10 shares during the last quarter. Mycio Wealth Partners LLC increased its stake in Thermo Fisher Scientific by 1.6% in the second quarter. Mycio Wealth Partners LLC now owns 711 shares of the company’s stock valued at $105,000 after buying an additional 11 shares during the last quarter. SSI Investment Management Inc. increased its stake in Thermo Fisher Scientific by 1.2% in the second quarter. SSI Investment Management Inc. now owns 1,879 shares of the company’s stock valued at $276,000 after buying an additional 23 shares during the last quarter. Finally, Smithfield Trust Co. increased its stake in Thermo Fisher Scientific by 0.5% in the second quarter. Smithfield Trust Co. now owns 5,658 shares of the company’s stock valued at $836,000 after buying an additional 29 shares during the last quarter. 87.38% of the stock is owned by institutional investors and hedge funds.

Thermo Fisher Scientific Company Profile

Related posts

Leave a Comment